CN Healthy Food Tech Group Corp. (UCFI) · Oct 13, 2026 · Delisting
Listing preserved — Remain listed, subject to a one-year Discretionary Panel Monitor
CN Healthy Food Tech’s Nasdaq listing survives a delisting challenge, but a strict one-year monitor and trading uncertainty keep the overhang intact.
CN Healthy Food Tech is a newly Nasdaq-listed Chinese health-food company whose operating subsidiaries focus on health-food products using AI and biotechnology; its U.S. listing has been tangled in an unresolved CSRC disclosure issue since the 2025 listing.
The immediate delisting threat has been avoided. Nasdaq’s Panel found the company’s disclosure about the CSRC application materially incomplete, but allowed the common stock and warrants to remain listed after considering the CSRC investigation’s closure, the company’s remedial steps, and the harm delisting would cause shareholders. The Panel “determined, pursuant to Nasdaq Listing Rule 5815(c)(4), to permit the Company to remain listed.”
This is a reprieve, not a clean reset. Nasdaq imposed a one-year Discretionary Panel Monitor, under which a new listing deficiency would trigger a Staff Delisting Determination without the usual compliance plan or cure period. 〔0〕 That makes the outcome materially better than an immediate delisting, but leaves the company with little room for another compliance mistake.
The company has upgraded its compliance machinery, but the need for it confirms the seriousness of the failure. Measures include replacing prior PRC counsel, creating a Compliance and Risk Management Department, formal disclosure controls, multilevel review of capital-markets communications, and a board with four independent directors. 〔1〕 These actions address the specific disclosure breakdown, but they do not erase the fact that Nasdaq found a material omission to investors.
Trading remains an unresolved practical issue. The filing says there is no assurance that trading in the listed securities will resume in the near future, so preserving the listing does not yet restore normal market access. The company also does not plan to seek Listing Council review, although the Council can independently call the decision for review within 45 calendar days. 〔2〕
Bottom line: This removes the worst-case outcome—immediate Nasdaq delisting—but replaces it with a fragile, closely monitored listing and no guaranteed trading resumption. It advances the company’s market-access story, without fully resolving it.
Nasdaq Listing Council review decision, if called
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!